ROYCE & ASSOCIATES LP - BIND THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of BIND THERAPEUTICS INC
ValueSharesWeighting
Q4 2014$11,000
-98.7%
2,000
-96.4%
0.00%
-100.0%
Q4 2013$830,00055,0000.00%
Other shareholders
BIND THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 155,000$2,123,500,0001.67%
EMERALD MUTUAL FUND ADVISERS TRUST 604,207$8,426,0000.50%
BVF INC/IL 150,000$2,264,0000.40%
EMERALD ADVISERS, LLC 419,752$6,334,0000.34%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 256,384$3,869,0000.20%
Alyeska Investment Group, L.P. 62,087$937,0000.04%
THOMPSON DAVIS & CO., INC. 1,500$23,0000.04%
PRELUDE CAPITAL MANAGEMENT, LLC 13,000$196,0000.03%
SSI INVESTMENT MANAGEMENT LLC 23,580$356,0000.03%
TFS CAPITAL LLC 20,933$316,0000.02%
View complete list of BIND THERAPEUTICS INC shareholders